* Ratio is calculated based on latest financial & current share price.
(All Amount in INR Millions)
(All Amount in INR Millions)
(All Amount in INR Millions)
PharmEasy is digital India’s digital consumer healthcare app. Referred to as a super app, PharmEasy offers customers on-demand access to home delivery for a comprehensive range of prescriptions and OTC pharmaceuticals. PharmEasy offers consumer healthcare products, information, consultations, and diagnostics tests from renowned laboratories. The company is associated with trusted doctors and registered in-store pharmacies. Birthed in 2015, PharmEasy is currently registered with more than 25 million users. Moreover, with a market capitalization of approximately ₹ 300 crores, PharmEasy unlisted shares are presently a hot shot among investors and financial advisors.
Founded by Dharmil Seth and Dr Dhaval Shah, PharmEasy serves every habitable zip code. The initial idea was to give end users an online pharmacy, but with the inclusion of consultation from trusted doctors and diagnostic tests from renowned laboratories, the application turned out to be more comprehensive. Furthermore, the company closed a revenue of ₹5781 crores in the fiscal year 2021.
In the past few months, almost every firm was hit by its all-time low, and so was PharmEasy. However, India’s largest digital healthcare platform boasts the potential to overcome its low. PharmEasy stock price experienced a hike during November and December of 2021. The PharmEasy share price has now come to a still range, varying between ₹ 30 – ₹40 per share price. Moreover, with over 2.4 million transacting consumers, PharmEasy saw a growth rate of 220% in fiscal 2021.
PharmEasy got its first funding in the year 2016 and got merged with Ascent Health and five other firms to form the most effective digital healthcare platform in India – API Holdings. Currently, the company has a face value of ₹ 1 per equity share and consists of a total of 10000 shares.
PharmEasy, with its merger in 2020, has turned out to be the most prominent name in the industry. With API Holdings as the parent company, PharmEasy is determined to show a staging growth rate, and investors are anticipating nothing less from the firm. After Paytm, PharmEasy unlisted share prices are expected to hold the most significant gains. Moreover, PharmEasy share price today is at its best value, catering to the range of ₹ 30 – ₹40 per share. Though the PharmEasy stock price saw a low in the last few months, the data below clearly depicts that investors are not ready to sell their PharmEasy unlisted shares, further indicating their belief in the growth.
Apart from the great face & brand value, and investor belief, another reason for investing in PharmEasy is the stunning revenue generated by the company. Check the company data below:
From the above data, the growth of PharmEasy unlisted share price can be clearly anticipated to go up. Further, reports suggest that the platform is expected to grow at an annual rate of 18.1% till the end of 2023. Thus, if you want to invest, now is the time! PharmEasy unlisted shares are currently one of the best options for your investment portfolio.
PharmEasy unlisted shares are pretty easy to buy, especially with Stockify. We are here with an ensemble of details such as Key Performance Indicators, revenue growth, EBITDA margin reports, EPS growth, etc. Moreover, the experts at Stockify constantly keep track of the trends and changes in the PharmEasy unlisted shares price, and we update our prices as per the market fluctuation every day.
PharmEasy stock price is currently the talk of the room; you can check it above. Analyse and compare the key indicators, figure out your requirements and rely on our experts to guide you throughout the PharmEasy unlisted shares buying process. We will take care of everything – from guidance to documentation.
PharmEasy company share price is updated every day here at Stockify. We keep a close eye on PharmEasy stock price fluctuations and immediately update our prices as per the market trends on a daily basis. If you are interested in buying PharEasy Unlisted Shares, stay connected with us and keep a close tab on our prices. You can check the PharmEasy share price today.
In case you seek alternatives subscribe to our newsletter – we roll out regular updates regarding PharmEasy share price, market trends, and other indicators which assist in determining whether or not a share is beneficial for your portfolio. PharmEasy unlisted share price India is ₹ 35.7.
Portfolio diversification is essential, especially if you wish to cope with market fluctuations. Diversification is the best way to minimise the blow that hits while the market goes down. Stockify brings an array of unlisted shares from top-rated companies and pre-IPO shares at authentic prices. Apart from buying and selling PharmEasy unlisted shares, look at the best unlisted shares in the market. We bring you unlisted shares from all the sectors – healthcare, insurance, technology, finance, manufacturing, and many more. Take a peek at the PharmEasy share price today and also glance up other unlisted shares hosted by Stockify, as specified below:
Reliance Retail, boAT Unlisted Shares, Chennai Super Kings, Anglo-French Drugs & Industries, Hexaware Technologies Ltd, Five Star Business Finance Ltd Unlisted Shares, Fincare Small Finance Bank Ltd Unlisted Shares, Arohan Financial Services Unlisted Shares, Utkarsh Coreinvest Ltd Unlisted Shares, Fino Paytech Ltd Unlisted Shares, Hero Fincorp Ltd Unlisted Shares, National Stock Exchange Ltd Nse Unlisted Shares, National Commodity Derivatives Exchange Ltd Ncdex Unlisted Shares, MetroPolitan Stock Exchange MSEI Unlisted Shares, Capital, Small Finance Bank Ltd Unlisted Shares, and Motilal Oswal Home Finance Ltd Unlisted Shares.
Login To Buy PharmEasy Unlisted Shares Today